Zoetis (NY:ZTS)

Value stocks typically trade at discounts to the broader market, offering patient investors the opportunity to buy businesses when they’re out of favor. The ...

3 value stocks we think twice about

November 05, 2026

Fast lifecycle approvals, such as Simparica Duo, are how Zoetis plans to extend its core franchises beyond today's pressured pet care market.

Zoetis: 3 Key Takeaways for Long-Term Investors ↗

November 05, 2026

Competitive pressure eased in dermatology, but clinic visits softened

Topics Earnings

Zoetis (ZTS) Q3 2026 Earnings Call Transcript ↗

November 05, 2026

Animal health company Zoetis (NYSE:ZTS) reported revenue ahead of Wall Street’s expectations in Q3 2026, but revenue fell by 1.3% year on year to $2.39 billi...

Topics Earnings

Zoetis (NYSE:ZTS) Dividend Quality Backed by Strong Profitability and Health Ratings ↗

November 02, 2026

Via Chartmill

Zoetis (NYSE:ZTS): A Quality Investing Case Study in Animal Health ↗

October 14, 2026

Via Chartmill

Zoetis (NYSE:ZTS) posts better-than-expected sales in Q3 2026

November 05, 2026

Zoetis Announces Third Quarter 2026 Results; Highlights Progress Advancing Innovation Across Diversified Portfolio and Narrows Full Year 2026 Revenue Guidance, Raises Full Year 2026 Adjusted EPS Guidance

November 05, 2026

From Zoetis Inc.

Animal health company Zoetis (NYSE:ZTS) will be reporting earnings this Thursday before market hours. Here’s what to look for. Zoetis missed analysts’ revenu...

Earnings to watch: Zoetis (ZTS) reports Q3 results tomorrow

November 03, 2026

Personal health and wellness is one of the many secular tailwinds for healthcare companies. Shareholders who bet on the industry have been rewarded lately as...

Topics Artificial Intelligence

1 healthcare stock with impressive fundamentals and 2 we ignore

November 01, 2026

The stocks listed here yield up to 5.8%.

Topics Economy

Zoetis (NYSE:ZTS): A Quality Dividend Stock for Income Investors With Room to Grow ↗

October 09, 2026

Via Chartmill

Zoetis (NYSE:ZTS) Looks Like a Decent Value Stock ↗

September 25, 2026

Via Chartmill

Zoetis (NYSE:ZTS): A Quality Dividend Stock for Dividend Investors ↗

September 14, 2026

Via Chartmill

Zoetis (NYSE:ZTS) Offers Value and Quality in One Attractive Package ↗

September 01, 2026

Via Chartmill

3 Absurdly Cheap Dividend Stocks to Buy for Under $100 Right Now ↗

October 27, 2026

Zoetis Receives FDA Approval for Convenia® RTU for Dogs (cefovecin injectable suspension), Helping More Medium and Large Dogs Access Single-Injection Treatment

Topics Bonds

October 20, 2026

From Zoetis Inc.

Zoetis has gotten torched over the last six months - since April 2026, its stock price has dropped 37.6% to $75.34 per share. This was partly due to its soft...

3 Reasons ZTS is Risky and 1 Stock to Buy Instead

October 15, 2026

Zoetis Appoints Iris Knobloch to its Board of Directors

October 13, 2026

From Zoetis Inc.

As the craze of earnings season draws to a close, here’s a look back at some of the most exciting (and some less so) results from Q2. Today, we are looking a...

Branded Pharmaceuticals Stocks Q2 In Review: Zoetis (NYSE:ZTS) Vs Peers

October 12, 2026

A Once-in-a-Decade Opportunity: 2 Magnificent Dividend Stocks Down 34% to 52% I'm Buying Right Now ↗

Topics Artificial Intelligence Intellectual Property

October 09, 2026

Whether you want a higher 3% dividend yield or a quickly growing dividend that yields 1.2%, these two stocks look like rare opportunities.

Topics Artificial Intelligence

Zoetis Declares Fourth Quarter 2026 Dividend

October 08, 2026

From Zoetis Inc.

New Peer-Reviewed Publication on Laboratory Study That Demonstrated Simparica Trio® Protected 3x More Dogs From Infection With a Resistant Heartworm Isolate Than NexGard® Plus1

October 06, 2026

From Zoetis Inc.

Zoetis to Host Webcast and Conference Call on Third Quarter 2026 Financial Results

September 24, 2026

From Zoetis Inc.

Many investors pay attention to mid-cap stocks because they have established business models and expansive market opportunities. However, their paths to beco...

1 Mid-Cap Stock with Exciting Potential and 2 We Turn Down

September 21, 2026

Zoetis (NYSE:ZTS) executives said the company remains confident in its previously issued guidance despite pressure in the U.S. companion-animal market, citing a weaker pet-care environment and...

Zoetis Stands by Guidance as Pet-Care Weakness and Competition Pressure Sales ↗

September 18, 2026

Via MarketBeat

1 Oversold Stock Ready to Bounce Back and 2 Facing Challenges

September 11, 2026

Rock-bottom prices don’t always mean rock-bottom businesses. The stocks we’re examining today have all touched their 52-week lows, creating a classic investo...

Zoetis to Participate in the Morgan Stanley 24th Annual Global Healthcare Conference

September 02, 2026

From Zoetis Inc.

The stocks in this article have caught Wall Street’s attention in a big way, with price targets implying returns above 20%. But investors should take these f...

What's going on in today's session: S&P500 movers ↗

August 28, 2026

Via Chartmill

3 of Wall Street’s Favorite Stocks We’re Skeptical Of

August 21, 2026

These stocks have been generous with their dividend increases, and more may be on the way.

3 High-Yielding Dividend Stocks That Have Doubled Their Payouts in 5 Years ↗

August 19, 2026